Neratinib is a big deal for breast cancer that’s HER2-positive. It’s all about stopping something called EGFR/HER2 signaling. You can get it in these 40 mg tablets.
The usual dose is 240 mg, taken once a day with food. The tablets come in bottles with 180 of them. The tablets are just the right size for taking every day, and the packaging keeps them fresh and easy to store.
The dosing is all about meeting the needs of people with HER2-positive breast cancer. The goal is to help manage the disease and make things better for the patients.
